Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin Watanabe

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
Research and Practice in Thrombosis and Haemostasis|June 6, 2024
Mitral regurgitation is associated with similar loss of von Willebrand factor large multimers but lower frequency of anemia compared with aortic stenosisHiroshi Takiguchi, Mizuki Miura, Shin-Ichi Shirai, et al.
Research and Practice in Thrombosis and Haemostasis|January 25, 2024
von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosisNoriyuki Okubo, Shingo Sugawara, Tohru Fujiwara, et al.
Circulation. Population Health and Outcomes|February 16, 2026
Changes in Demographics, Initial Treatment Strategies, and Clinical Outcomes of Severe Aortic Stenosis in the Pre- and Post-TAVR Era in JapanYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
JACC. Advances|August 27, 2025
Cardiac Damage Stages and Clinical Outcomes in Patients With Severe Aortic StenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|November 28, 2024
Availability of transcatheter aortic valve implantation across hospitals and differences in strategies and clinical outcomes in patients with severe aortic stenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 18, 2024
Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and HypertensionKo Yamamoto, Yasuaki Takeji, Tomohiko Taniguchi, et al.
The American Journal of Cardiology|June 9, 2025
Early Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Patients With Severe Aortic StenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|May 26, 2026
Cardiac damage stages at follow-up and subsequent clinical outcomes in patients with severe aortic stenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 21, 2025
Prognostic Value of the 6-Minute Walk Test in Patients With Severe Aortic StenosisNorio Kanamori, Yasuaki Takeji, Tomohiko Taniguchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 8, 2024
Concomitant Mitral Regurgitation in Severe Aortic Stenosis　- Insights From the CURRENT AS Registry-2Yuki Obayashi, Yasuaki Takeji, Tomohiko Taniguchi, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Research and Practice in Thrombosis and Haemostasis|June 6, 2024
Mitral regurgitation is associated with similar loss of von Willebrand factor large multimers but lower frequency of anemia compared with aortic stenosisHiroshi Takiguchi, Mizuki Miura, Shin-Ichi Shirai, et al.
Research and Practice in Thrombosis and Haemostasis|January 25, 2024
von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosisNoriyuki Okubo, Shingo Sugawara, Tohru Fujiwara, et al.
Circulation. Population Health and Outcomes|February 16, 2026
Changes in Demographics, Initial Treatment Strategies, and Clinical Outcomes of Severe Aortic Stenosis in the Pre- and Post-TAVR Era in JapanYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
JACC. Advances|August 27, 2025
Cardiac Damage Stages and Clinical Outcomes in Patients With Severe Aortic StenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|November 28, 2024
Availability of transcatheter aortic valve implantation across hospitals and differences in strategies and clinical outcomes in patients with severe aortic stenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 18, 2024
Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and HypertensionKo Yamamoto, Yasuaki Takeji, Tomohiko Taniguchi, et al.
The American Journal of Cardiology|June 9, 2025
Early Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Patients With Severe Aortic StenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|May 26, 2026
Cardiac damage stages at follow-up and subsequent clinical outcomes in patients with severe aortic stenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 21, 2025
Prognostic Value of the 6-Minute Walk Test in Patients With Severe Aortic StenosisNorio Kanamori, Yasuaki Takeji, Tomohiko Taniguchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 8, 2024
Concomitant Mitral Regurgitation in Severe Aortic Stenosis　- Insights From the CURRENT AS Registry-2Yuki Obayashi, Yasuaki Takeji, Tomohiko Taniguchi, et al.
Pageof 22